Mankind Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE634S01028
  • NSEID: MANKIND
  • BSEID: 543904
INR
2,660.00
30 (1.14%)
BSENSE

Nov 20

BSE+NSE Vol: 4.74 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
4,337.86
4,030.59
3,442.93
3,567.20
3,697.16
3,570.35
3,079.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,337.86
4,030.59
3,442.93
3,567.20
3,697.16
3,570.35
3,079.37
Raw Material Cost
674.81
684.85
554.95
553.04
594.36
585.68
554.25
Purchase of Finished goods
547.73
547.28
498.36
411.67
412.97
404.97
411.12
(Increase) / Decrease In Stocks
-18.32
-133.86
-94.94
13.28
54.84
62.94
-89.99
Employee Cost
948.94
913.50
751.60
823.71
825.18
783.41
715.80
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,013.45
962.63
803.08
846.07
888.48
886.58
805.00
Total Expenditure (Excl Depreciation)
3,166.61
2,974.40
2,513.05
2,647.77
2,775.83
2,723.58
2,396.18
Operating Profit (PBDIT) excl Other Income
1,171.25
1,056.19
929.88
919.43
921.33
846.77
683.19
Other Income
94.85
45.00
114.29
72.75
91.87
79.88
251.33
Operating Profit (PBDIT)
1,266.10
1,101.19
1,044.17
992.18
1,013.20
926.65
934.52
Interest
104.94
109.98
141.75
157.20
169.68
170.65
190.54
Exceptional Items
0.00
0.00
-23.16
-106.59
0.00
0.00
-4.34
Gross Profit (PBDT)
1,161.16
991.21
879.26
728.39
843.52
756.00
743.98
Depreciation
235.73
225.70
223.08
222.60
221.82
218.68
230.87
Profit Before Tax
929.11
769.45
659.17
509.00
624.02
540.49
515.43
Tax
212.99
195.36
99.75
95.12
103.84
95.87
86.44
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
712.44
570.15
556.43
410.67
517.86
441.45
426.67
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
-4.34
Net Profit
712.44
570.15
556.43
410.67
517.86
441.45
422.33
Share in Profit of Associates
3.68
3.94
2.99
3.21
2.32
3.17
2.32
Minority Interest
4.64
6.03
5.07
5.13
8.67
6.30
3.88
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
711.48
568.06
554.35
408.75
511.51
438.32
420.77
Equity Capital
41.30
41.30
41.28
41.28
41.28
41.26
41.26
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
17.23
13.75
13.43
9.9
12.39
10.62
10.2
Diluted Earnings per share
17.2
13.74
13.41
9.89
12.38
10.6
10.18
Operating Profit Margin (Excl OI)
27.0%
26.2%
27.01%
25.77%
24.92%
23.72%
22.19%
Gross Profit Margin
26.77%
24.59%
25.54%
20.42%
22.82%
21.17%
24.16%
PAT Margin
16.51%
14.24%
16.25%
11.6%
14.07%
12.45%
13.93%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 7.62% vs 17.07% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is 25.25% vs 2.47% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is 10.89% vs 13.58% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is -4.58% vs -22.41% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

Compare Quarterly Results Of Mankind Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
4,337.86
7,403.93
-3,066.07
-41.41%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,337.86
7,403.93
-3,066.07
-41.41%
Raw Material Cost
674.81
1,523.74
-848.93
-55.71%
Purchase of Finished goods
547.73
1,312.59
-764.86
-58.27%
(Increase) / Decrease In Stocks
-18.32
-202.59
184.27
90.96%
Employee Cost
948.94
1,474.61
-525.67
-35.65%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
1,013.45
1,907.80
-894.35
-46.88%
Total Expenditure (Excl Depreciation)
3,166.61
6,016.15
-2,849.54
-47.36%
Operating Profit (PBDIT) excl Other Income
1,171.25
1,387.78
-216.53
-15.60%
Other Income
94.85
151.16
-56.31
-37.25%
Operating Profit (PBDIT)
1,266.10
1,538.94
-272.84
-17.73%
Interest
104.94
16.74
88.20
526.88%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
1,161.16
1,522.20
-361.04
-23.72%
Depreciation
235.73
344.86
-109.13
-31.64%
Profit Before Tax
929.11
1,177.34
-248.23
-21.08%
Tax
212.99
320.82
-107.83
-33.61%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
712.44
856.52
-144.08
-16.82%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
712.44
856.52
-144.08
-16.82%
Share in Profit of Associates
3.68
-5.01
8.69
173.45%
Minority Interest
4.64
-26.03
30.67
117.83%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
711.48
877.54
-166.06
-18.92%
Equity Capital
41.30
161.57
-120.27
-74.44%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
17.23
10.86
6.37
58.66%
Diluted Earnings per share
17.20
10.85
6.35
58.53%
Operating Profit Margin (Excl OI)
27.00%
18.83%
0.00
8.17%
Gross Profit Margin
26.77%
20.66%
0.00
6.11%
PAT Margin
16.51%
11.62%
0.00
4.89%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 4,337.86 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 7.62% vs 17.07% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 17.33% vs 20.77% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 711.48 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 25.25% vs 2.47% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 39.09% vs -21.72% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,171.25 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 10.89% vs 13.58% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 27.13% vs 8.75% in Sep 2025

Quarterly - Interest
Interest 104.94 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -4.58% vs -22.41% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -38.15% vs 2,289.86% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.00%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025